
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Innogest Capital is a venture capital firm founded in 2006, headquartered in Italy. The firm operates from offices in Turin, Milan, Geneva, and San Francisco, managing investment funds totaling over €200 million. Innogest Capital focuses on providing capital to innovative companies, particularly in the technology and healthcare sectors. The firm has established a reputation for supporting early-stage and growth-stage companies, aiming to foster entrepreneurship and innovation in Europe.
Since its inception, Innogest Capital has evolved to become a key player in the European venture capital landscape. The firm has a diverse Limited Partner (LP) base, which includes institutional investors and private entities. Notable milestones include the launch of the Italian Patents Competition, which promotes projects based on patents developed in Italy, particularly in life sciences and digital sectors.
Innogest Capital primarily invests in the healthcare and technology sectors, with a strong emphasis on early-stage ventures. The firm targets companies that demonstrate global ambitions, particularly in areas such as digital health, medical technologies, and digital platforms. Their investment strategy is designed to support innovative companies that are poised for growth in these fields.
Innogest Capital's specific interests include cardiovascular diseases, neurological disorders, and oncology. The firm typically engages in Seed, Series A, and Growth Equity stages, providing capital to help startups scale and achieve their objectives. Innogest seeks founders who are passionate about their projects and possess a clear vision for their companies.
Innogest Capital has built a notable portfolio of companies, particularly in the healthcare sector. Key portfolio companies include:
Claudio Giuliano: Managing Partner with extensive experience in venture capital and a background in technology investments.
Stefano Molino: Partner, specializing in early-stage investments and strategic growth.
Hadi Abderrahim: Head of Strategy Healthcare, focusing on healthcare innovation and market trends.
Hiroaki Tanaka: Head of Personalized Medicine, with expertise in medical technologies and personalized healthcare solutions.
Marco Pinciroli: Partner, experienced in managing venture capital funds and supporting startups.
Johann Tse: Venture Partner, bringing a wealth of knowledge in technology investments.
Simona Roggero: Venture Partner, focused on supporting innovative healthcare startups.
Riccardo Palmisano: Venture Partner, with a strong background in venture capital and entrepreneurship.
To pitch Innogest Capital, founders should send their proposals via email to info@innogestcapital.com. A comprehensive pitch deck should include details about the business model, market opportunity, and team structure. Response times may vary, but founders are encouraged to follow up if they do not receive a timely reply.
Innogest Capital runs the Italian Patents Competition, which offers a €250,000 investment for projects based on patents developed in Italy. This program is designed to promote economic valuation and international competitiveness of patents, particularly in the life sciences and digital sectors.
Innogest Capital recently participated in the Italian Patents Competition, which awards €250,000 for projects based on patents developed in Italy. This initiative aims to enhance the international competitiveness of Italian research.
Additionally, the firm continues to expand its portfolio in the healthcare sector, focusing on innovative companies that address critical medical challenges.
What are Innogest Capital's investment criteria?
Innogest Capital focuses on early-stage and growth-stage companies in the healthcare and technology sectors. They look for innovative startups with global ambitions and a strong team.
How can I apply or pitch to Innogest Capital?
Founders can reach out to Innogest Capital via email at info@innogestcapital.com. A well-prepared pitch deck that outlines the business model, market opportunity, and team is essential.
What makes Innogest Capital different from other VC firms?
Innogest Capital has a strong focus on the healthcare and technology sectors, leveraging over 100 years of cumulative professional experience among its team members to support startups effectively.
What is the geographic scope of Innogest Capital's investments?
The firm primarily invests in companies located in Europe, particularly those that are innovating in the healthcare and technology sectors.
What is the typical check size for investments?
Innogest Capital invests at various stages, including Seed and Series A, with check sizes that align with the needs of early-stage and growth-stage companies.
What kind of post-investment involvement does Innogest Capital have?
Innogest Capital actively supports its portfolio companies through mentorship, operational support, and strategic guidance, often involving team members in board roles.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.